Innovative clinical trials focusing on breast cancer treatments, including studies of ribociclib with endocrine therapy for HR-positive, HER2-negative cases. Additional research encompasses various blood cancers, including lymphomas and leukemia.

Early-stage breast cancer therapy
Diffuse large B-cell lymphoma treatments
Acute myeloid leukemia management

Cutting-edge research evaluating novel therapeutic combinations and treatment approaches for better patient outcomes.

02 Dermatological Studies

Comprehensive research into chronic skin conditions, including trials for plaque psoriasis and atopic dermatitis. Studies evaluate new therapeutic agents for moderate to severe cases.

Hidradenitis suppurativa treatments
Novel psoriasis therapies
Atopic dermatitis management

Focus on developing effective treatments for persistent skin conditions that significantly impact quality of life.

03 Gastrointestinal Research

Advanced studies in inflammatory bowel diseases, particularly Crohn's disease and ulcerative colitis. Trials investigate innovative therapies for moderate to severe cases.

Long-term disease management
Combination therapy approaches
Treatment-resistant cases

Investigation of new therapeutic options for patients with inadequate response to conventional treatments.

Back to Germany All countries

Clinical trials in Kiel – page 33

433 trials in Kiel

Myelofibrosis

Study on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment

Hepatocellular carcinoma

Study on Regorafenib and Pembrolizumab for Patients with Intermediate-Stage Liver Cancer

Hormone receptor positive breast cancer+1

Study of Giredestrant, Triptorelin, and Anastrozole in Premenopausal Women with ER-Positive/HER2-Negative Early Breast Cancer

Neoplasm malignant

Study on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer

Pleural mesothelioma

Study of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma

Migraine+2

Study on Long-Term Safety of Atogepant for Preventing Migraine in Patients with Chronic or Episodic Migraine

Colitis ulcerative

Study on Long-Term Safety and Effectiveness of Upadacitinib for Patients with Ulcerative Colitis

Activated PI3 kinase delta syndrome

Study on Leniolisib for Patients with Activated Phosphoinositide 3-Kinase Delta Syndrome and Impaired Liver Function

Squamous cell carcinoma

Study of Cemiplimab for Patients with Stage II to IV Cutaneous Squamous Cell Carcinoma

Metastatic malignant melanoma

Study on Botensilimab and Balstilimab for Patients with Advanced Melanoma Resistant to Previous Treatments

Plasma cell myeloma

Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Hepatitis D

Study on Bulevirtide Treatment for Patients with Chronic Hepatitis D

Filter the trials

Other cities in Germany

Clinical research in Kiel

Prefer not to search? Our Concierge searches the trials for you.